Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Nuvation Bio Inc’s current trading price is -46.35% away from its 52-week high, while its distance from the 52-week low is 38.31%. The stock’s price range during this period has varied between $1.54 and $3.97. The company, active in the Healthcare sector, saw a trading volume of around 2.66 million for the day, considerably lower average daily volume of 5.79 million observed over the last three months.
The current stock price for Nuvation Bio Inc (NUVB) is $2.13. The stock experienced a significant increase during the last trading session, reaching $10.0 after opening at $2.15. It dipped to a low of $5.0 before ultimately closing at $2.14.
Nuvation Bio Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $3.97 on 07/31/24, with the lowest value being $1.54 on 04/07/25.
How Financial Performance Impacts Market Capitalization
Nuvation Bio Inc (NUVB) has experienced a quarterly rise of 7.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 724.76M and boasts a workforce of 220 employees.
Decoding Analysts’ Ratings for Nuvation Bio Inc
As of right now, 4 analysts are rating Nuvation Bio Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.06, with a change in price of -0.17. Similarly, Nuvation Bio Inc recorded 4,726,298 in trading volume during the last 100 days, posting a change of -7.61%.
How NUVB’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for NUVB stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.01.
NUVB Stock Stochastic Average
As of today, the raw stochastic average of Nuvation Bio Inc over the past 50 days is 48.26%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 64.53%. Additionally, the Stochastic %K and %D values for the company were 68.02% and 68.35%, respectively, over the past 20 days.
NUVB Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -36.23% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -23.38%. Over the past 30 days, the price of NUVB has fallen by 17.68%. And in the last five days, it has surged by 3.90%.
